Skip to main content
Top
Published in: Clinical Rheumatology 1/2019

01-01-2019 | Original Article

Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity

Authors: Eduardo Martín-Nares, Diego Zuñiga-Tamayo, Andrea Hinojosa-Azaola

Published in: Clinical Rheumatology | Issue 1/2019

Login to get access

Abstract

We aimed to estimate the frequency of overlap of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with systemic autoimmune diseases. Retrospective single-center study to identify patients with AAV diagnosis and concomitant autoimmune systemic diseases, simultaneously, before or after the diagnosis of AAV. Sociodemographic characteristics, such as comorbidities; follow-up time; type of AAV; disease duration; relapses; treatment and response; clinical, serological, and histological characteristics; disease activity and damage; prognosis; dialysis requirements, and death were assessed. Twenty-eight of two hundred and forty-seven patients (11.3%) with AAV had a concomitant diagnosis of autoimmune disease. The predominant AAV type was renal-limited vasculitis (39%), followed by granulomatosis with polyangiitis (29%), mycroscopic polyangiitis (25%), and eosinophilic granulomatosis with polyangiitis (7%). Mean age at AAV diagnosis was 50 ± 17 years and 24/28 were ANCA positive. The main clinical manifestations were renal (79%), otorhinolaryngologic (43%), and pulmonary and peripheral neuropathy (32%). Sixteen patients (57%) experienced partial or total remission at a median follow-up of 34 months, and four patients (14%) died. The most frequent autoimmune disease overlapped was rheumatoid arthritis (39%), followed by Sjögren’s syndrome and systemic sclerosis (14%), mixed connective tissue disease (11%), systemic lupus erythematosus and juvenile idiopathic arthritis (7%), and ankylosing spondylitis and IgG4-related disease (4%). In nine patients (32%), both diagnoses were simultaneous; in the rest, median time elapsed between the autoimmune disease and AAV diagnosis was 173 months. The prevalence of overlap AAV with other autoimmune diseases was low. The most common AAV phenotype was renal-limited vasculitis, and the most frequent overlap disease was rheumatoid arthritis.
Appendix
Available only for authorised users
Literature
2.
go back to reference Perez-Alamino R, Maldonado-Ficco H (2015) New insights on biomarkers in systemic vasculitis. Curr Rheumatol Rep 17:12CrossRefPubMed Perez-Alamino R, Maldonado-Ficco H (2015) New insights on biomarkers in systemic vasculitis. Curr Rheumatol Rep 17:12CrossRefPubMed
3.
go back to reference Rodríguez-Reyna TA, Alarcón-Segovia D (2005) Overlap syndromes in the context of shared autoimmunity. Autoimmunity 38(3):219–223CrossRefPubMed Rodríguez-Reyna TA, Alarcón-Segovia D (2005) Overlap syndromes in the context of shared autoimmunity. Autoimmunity 38(3):219–223CrossRefPubMed
4.
go back to reference Braun MG, Csernok E, Schimitt WH, Gross WL (1996) Indicence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 23(5):826–830PubMed Braun MG, Csernok E, Schimitt WH, Gross WL (1996) Indicence, target antigens, and clinical implications of antineutrophil cytoplasmic antibodies in rheumatoid arthritis. J Rheumatol 23(5):826–830PubMed
5.
go back to reference Draibe J, Salama AD (2015) Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome. Springerplus 1(4):50CrossRef Draibe J, Salama AD (2015) Association of ANCA associated vasculitis and rheumatoid arthritis: a lesser recognized overlap syndrome. Springerplus 1(4):50CrossRef
6.
go back to reference Foray N, Hudali T, Papireddy M, Gao J (2016) A case report describing a rare presentation of simultaneous occurrence of MPO-ANCA-associated vasculitis and rheumatoid arthritis. Case Rep Nephrol 2016:9340524PubMedPubMedCentral Foray N, Hudali T, Papireddy M, Gao J (2016) A case report describing a rare presentation of simultaneous occurrence of MPO-ANCA-associated vasculitis and rheumatoid arthritis. Case Rep Nephrol 2016:9340524PubMedPubMedCentral
7.
go back to reference Góis M, Messias A, Carvalho D, Carvalho F, Sousa H, Sousa J, Nolasco F (2017) MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis: a case report and review of literature. J Nephropathol 6(2):58–62CrossRefPubMed Góis M, Messias A, Carvalho D, Carvalho F, Sousa H, Sousa J, Nolasco F (2017) MPO-ANCA-associated necrotizing glomerulonephritis in rheumatoid arthritis: a case report and review of literature. J Nephropathol 6(2):58–62CrossRefPubMed
8.
go back to reference Campochiaro C, Scotti R, Margari S, Giorgione V, Mellone R, Mangili G, del Maschio A, Tresoldi M (2016) A case of granulomatosis with polyangiitis: rheumatoid arthritis overlap syndrome presenting as cervical cancer successfully treated with rituximab. Intern Med J 46(6):745–746CrossRefPubMed Campochiaro C, Scotti R, Margari S, Giorgione V, Mellone R, Mangili G, del Maschio A, Tresoldi M (2016) A case of granulomatosis with polyangiitis: rheumatoid arthritis overlap syndrome presenting as cervical cancer successfully treated with rituximab. Intern Med J 46(6):745–746CrossRefPubMed
9.
go back to reference Wedderburn LR, Kwan JT, Thompson PW, Rudge SR (1992) Juvenile chronic arthiritis and Wegener’s granulomatosis. Br J Rheumatol 31(2):121–123CrossRefPubMed Wedderburn LR, Kwan JT, Thompson PW, Rudge SR (1992) Juvenile chronic arthiritis and Wegener’s granulomatosis. Br J Rheumatol 31(2):121–123CrossRefPubMed
10.
go back to reference Dhib M, Prieur AM, Courville S, Niaudet P, Francois A, Godin M, Fillastre JP (1996) Crescentic glomerulonephritis in juvenile chronic arthritis. J Rheumatol 23(9):1636–1640PubMed Dhib M, Prieur AM, Courville S, Niaudet P, Francois A, Godin M, Fillastre JP (1996) Crescentic glomerulonephritis in juvenile chronic arthritis. J Rheumatol 23(9):1636–1640PubMed
11.
go back to reference Jakez-Ocampo J, Ramírez J, Paulín-Vera CM, Flores-Suárez LF, Reyes E, Llorente L (2010) Juvenile idiopathic arthritis and Wegener’s granulomatosis—causal or casual acquaintances? Joint Bone Spine 77(4):349–350CrossRefPubMed Jakez-Ocampo J, Ramírez J, Paulín-Vera CM, Flores-Suárez LF, Reyes E, Llorente L (2010) Juvenile idiopathic arthritis and Wegener’s granulomatosis—causal or casual acquaintances? Joint Bone Spine 77(4):349–350CrossRefPubMed
12.
go back to reference Belot A, Bader-Meunier B, Niaudet P, Salomon R, Prieur AM, Noel LH, Quartier P (2012) ANCA-associated glomerulonephritis in systemic-onset juvenile idiopathic arthritis. Am J Kidney Dis 59(3):439–443CrossRefPubMed Belot A, Bader-Meunier B, Niaudet P, Salomon R, Prieur AM, Noel LH, Quartier P (2012) ANCA-associated glomerulonephritis in systemic-onset juvenile idiopathic arthritis. Am J Kidney Dis 59(3):439–443CrossRefPubMed
13.
go back to reference Ooi KG, Drummond SR, Thompson KJ, Roberts F, Kemp EG (2004) Churg-Strauss syndrome presenting with conjunctival nodules in association with Candida albicans and ankylosing spondylitis. Clin Exp Opththalmol 32(4):441–443CrossRef Ooi KG, Drummond SR, Thompson KJ, Roberts F, Kemp EG (2004) Churg-Strauss syndrome presenting with conjunctival nodules in association with Candida albicans and ankylosing spondylitis. Clin Exp Opththalmol 32(4):441–443CrossRef
14.
go back to reference Calvo-Romero JM, Romero-Requena J, Arévalo-Lorido JC (2003) Antineutrophil cytoplasmic antibodies (ANCA) in ankylosing spondylitis. Clin Exp Rheumatol 21(4):528PubMed Calvo-Romero JM, Romero-Requena J, Arévalo-Lorido JC (2003) Antineutrophil cytoplasmic antibodies (ANCA) in ankylosing spondylitis. Clin Exp Rheumatol 21(4):528PubMed
15.
go back to reference Yu F, Tan Y, Liu G, Wang SX, Zou WZ, Zhao MH (2009) Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 76(3):307–317CrossRefPubMed Yu F, Tan Y, Liu G, Wang SX, Zou WZ, Zhao MH (2009) Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 76(3):307–317CrossRefPubMed
16.
go back to reference Sen D, Isenberg DA (2003) Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12:651–658CrossRefPubMed Sen D, Isenberg DA (2003) Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12:651–658CrossRefPubMed
17.
go back to reference Jarrot PA, Chiche L, Hervier B, Daniel L, Vuiblet V, Bardin N, Bertin D, Terrier B, Amoura Z, Andrés E, Rondeau E, Hamidou M, Pennaforte JL, Halfon P, Daugas E, Dussol B, Puéchal X, Kaplanski G, Jourde-Chiche N (2016) Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis. Medicine (Baltimore) 95(22):e3748CrossRef Jarrot PA, Chiche L, Hervier B, Daniel L, Vuiblet V, Bardin N, Bertin D, Terrier B, Amoura Z, Andrés E, Rondeau E, Hamidou M, Pennaforte JL, Halfon P, Daugas E, Dussol B, Puéchal X, Kaplanski G, Jourde-Chiche N (2016) Systemic lupus erythematosus and antineutrophil cytoplasmic antibody-associated vasculitis overlap syndrome in patients with biopsy-proven glomerulonephritis. Medicine (Baltimore) 95(22):e3748CrossRef
18.
go back to reference Guellec D, Cornec-Le Gall E, Groh M et al (2015) ANCA-associated vasculitis in patients with primary Sjögren’s syndrome: detailed analysis of 7 new cases and systematic literature review. Autoimmun Rev 14(8):742–750CrossRefPubMed Guellec D, Cornec-Le Gall E, Groh M et al (2015) ANCA-associated vasculitis in patients with primary Sjögren’s syndrome: detailed analysis of 7 new cases and systematic literature review. Autoimmun Rev 14(8):742–750CrossRefPubMed
19.
go back to reference Font J, Ramos-Casals M, Cervera R et al (1998) Antineutrophil cytoplasmic antibodies in primary Sjögren’s syndrome: prevalence and clinical significance. Br J Rheumatol 37(12):1287–1291CrossRefPubMed Font J, Ramos-Casals M, Cervera R et al (1998) Antineutrophil cytoplasmic antibodies in primary Sjögren’s syndrome: prevalence and clinical significance. Br J Rheumatol 37(12):1287–1291CrossRefPubMed
20.
go back to reference Kubota K, Ueno T, Mise K, Hazue R, Suwabe T, Kikuchi K, Hoshino J, Sumida K, Hayami N, Takaichi K, Fujii T, Ohashi K, Nonomura Y, Ubara Y (2015) ANCA-associated vasculitis in a patient with systematic sclerosis and Sjögren’s syndrome: a case report. Case Rep Nephrol Dial 5(2):113–117CrossRefPubMedPubMedCentral Kubota K, Ueno T, Mise K, Hazue R, Suwabe T, Kikuchi K, Hoshino J, Sumida K, Hayami N, Takaichi K, Fujii T, Ohashi K, Nonomura Y, Ubara Y (2015) ANCA-associated vasculitis in a patient with systematic sclerosis and Sjögren’s syndrome: a case report. Case Rep Nephrol Dial 5(2):113–117CrossRefPubMedPubMedCentral
21.
go back to reference Ghorbel IB, Feki NB, Salem TB, Hamzaoui A, Khanfir M, Lamloum M, Miled M, Houman MH (2015) Microscopic polyangiitis associated with primary biliary cirrhosis, Sjogren’s syndrome and Hashimoto’s thyroiditis. Saudi J Kidney Dis Transpl 26(2):359–362CrossRefPubMed Ghorbel IB, Feki NB, Salem TB, Hamzaoui A, Khanfir M, Lamloum M, Miled M, Houman MH (2015) Microscopic polyangiitis associated with primary biliary cirrhosis, Sjogren’s syndrome and Hashimoto’s thyroiditis. Saudi J Kidney Dis Transpl 26(2):359–362CrossRefPubMed
22.
go back to reference Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R (2003) Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol 30(6):1248–1252PubMed Khanna D, Aggarwal A, Bhakuni DS, Dayal R, Misra R (2003) Bactericidal/permeability-increasing protein and cathepsin G are the major antigenic targets of antineutrophil cytoplasmic autoantibodies in systemic sclerosis. J Rheumatol 30(6):1248–1252PubMed
23.
go back to reference Akimoto S, Ishikawa O, Tamura T et al (1996) Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis. Br J Dermatol 134(3):407–410CrossRefPubMed Akimoto S, Ishikawa O, Tamura T et al (1996) Antineutrophil cytoplasmic autoantibodies in patients with systemic sclerosis. Br J Dermatol 134(3):407–410CrossRefPubMed
24.
go back to reference Derrett-Smith EC, Nihtyanova SI, Harvey J, Salama AD, Denton CP (2013) Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. Rheumatology (Oxford) 52(10):1824–1831CrossRef Derrett-Smith EC, Nihtyanova SI, Harvey J, Salama AD, Denton CP (2013) Revisiting ANCA-associated vasculitis in systemic sclerosis: clinical, serological and immunogenetic factors. Rheumatology (Oxford) 52(10):1824–1831CrossRef
25.
go back to reference Quéméneur T, Mouthon L, Cacoub P, Meyer O, Michon-Pasturel U, Vanhille P, Hatron PY, Guillevin L, Hachulla E (2013) Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature. Medicine (Baltimore) 92(1):1–9CrossRef Quéméneur T, Mouthon L, Cacoub P, Meyer O, Michon-Pasturel U, Vanhille P, Hatron PY, Guillevin L, Hachulla E (2013) Systemic vasculitis during the course of systemic sclerosis: report of 12 cases and review of the literature. Medicine (Baltimore) 92(1):1–9CrossRef
26.
go back to reference Guilpain P, Chéreau C, Goulvestre C et al (2011) The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis. Eur Respir J 37(6):1503–1513CrossRefPubMed Guilpain P, Chéreau C, Goulvestre C et al (2011) The oxidation induced by antimyeloperoxidase antibodies triggers fibrosis in microscopic polyangiitis. Eur Respir J 37(6):1503–1513CrossRefPubMed
27.
go back to reference Tubery A, Fortenfant F, Combe B, Abreu I, Bossuyt X, Chretien P, Desplat-Jégo S, Fabien N, Hue S, Johanet C, Lakomy D, Vincent T, Daïen CI (2016) Clinical association of mixed connective tissue disease and granulomatosis with polyangiitis: a case report and systematic screening of anti-U1RNP and anti-PR3 auto-antibody double positivity in ten European hospitals. Immunol Res 64(5–6):1243–1246CrossRefPubMed Tubery A, Fortenfant F, Combe B, Abreu I, Bossuyt X, Chretien P, Desplat-Jégo S, Fabien N, Hue S, Johanet C, Lakomy D, Vincent T, Daïen CI (2016) Clinical association of mixed connective tissue disease and granulomatosis with polyangiitis: a case report and systematic screening of anti-U1RNP and anti-PR3 auto-antibody double positivity in ten European hospitals. Immunol Res 64(5–6):1243–1246CrossRefPubMed
28.
go back to reference Hernández-Molina G, Reyes E, Crispín JC (2006) ANCA associated glomerulonephritis in a patient with mixed connective tissue disease. Ann Rheum Dis 65(3):410–411CrossRefPubMedPubMedCentral Hernández-Molina G, Reyes E, Crispín JC (2006) ANCA associated glomerulonephritis in a patient with mixed connective tissue disease. Ann Rheum Dis 65(3):410–411CrossRefPubMedPubMedCentral
29.
go back to reference Ando M, Goto A, Yamasue M, Usagawa Y, Oka H, Shigenaga T, Kadota JI et al (2017) Pulmonary-limited granulomatosis with polyangiitis coexisting with mixed connective tissue disease. Tohoku J Exp Med 242(2):109–114CrossRefPubMed Ando M, Goto A, Yamasue M, Usagawa Y, Oka H, Shigenaga T, Kadota JI et al (2017) Pulmonary-limited granulomatosis with polyangiitis coexisting with mixed connective tissue disease. Tohoku J Exp Med 242(2):109–114CrossRefPubMed
30.
go back to reference Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, Yi ES (2013) IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol 44(11):2432–2437CrossRefPubMed Chang SY, Keogh KA, Lewis JE, Ryu JH, Cornell LD, Garrity JA, Yi ES (2013) IgG4-positive plasma cells in granulomatosis with polyangiitis (Wegener’s): a clinicopathologic and immunohistochemical study on 43 granulomatosis with polyangiitis and 20 control cases. Hum Pathol 44(11):2432–2437CrossRefPubMed
31.
go back to reference Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, Guillevin L, Vaglio A, Terrier B, French Vasculitis Study Group (2017) Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16(10):1036–1043CrossRefPubMed Danlos FX, Rossi GM, Blockmans D, Emmi G, Kronbichler A, Durupt S, Maynard C, Luca L, Garrouste C, Lioger B, Mourot-Cottet R, Dhote R, Arlet JB, Hanslik T, Rouvier P, Ebbo M, Puéchal X, Nochy D, Carlotti A, Mouthon L, Guillevin L, Vaglio A, Terrier B, French Vasculitis Study Group (2017) Antineutrophil cytoplasmic antibody-associated vasculitides and IgG4-related disease: a new overlap syndrome. Autoimmun Rev 16(10):1036–1043CrossRefPubMed
32.
go back to reference Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, Bhalodia A, Sohani AR, Zhang L, Chari S, Sethi S, Fidler ME, Cornell LD (2011) IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 22(7):1343–1352CrossRefPubMedPubMedCentral Raissian Y, Nasr SH, Larsen CP, Colvin RB, Smyrk TC, Takahashi N, Bhalodia A, Sohani AR, Zhang L, Chari S, Sethi S, Fidler ME, Cornell LD (2011) IgG4-related tubulointerstitial nephritis. J Am Soc Nephrol 22(7):1343–1352CrossRefPubMedPubMedCentral
33.
go back to reference Della-Torre E, Lanzillotta M, Campochiaro C, Bozzalla E, Bozzolo E, Bandiera A, Bazzigaluppi E, Canevari C, Modorati G, Stone JH, Manfredi A, Doglioni C (2016) Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature. Medicine (Baltimore) 95(34):e4633CrossRef Della-Torre E, Lanzillotta M, Campochiaro C, Bozzalla E, Bozzolo E, Bandiera A, Bazzigaluppi E, Canevari C, Modorati G, Stone JH, Manfredi A, Doglioni C (2016) Antineutrophil cytoplasmic antibody positivity in IgG4-related disease: a case report and review of the literature. Medicine (Baltimore) 95(34):e4633CrossRef
34.
go back to reference Rincón JF, Cano DL, Morales SJ et al (2016) The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico. Clin Rheumatol 35(6):1457–1462CrossRefPubMed Rincón JF, Cano DL, Morales SJ et al (2016) The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico. Clin Rheumatol 35(6):1457–1462CrossRefPubMed
35.
go back to reference Zenteno JC, Correa-Gómez V, Pompa-Mera EN, Lima G, Pedroza-Seres M, Flores-Suárez LF (2016) The PTPN22 R620W polymorphism in anti-neutrophil cytoplasmic antibody-associated vasculitis in Mexican Mestizos. Rheumatology (Oxford) 55(12):2271–2273CrossRef Zenteno JC, Correa-Gómez V, Pompa-Mera EN, Lima G, Pedroza-Seres M, Flores-Suárez LF (2016) The PTPN22 R620W polymorphism in anti-neutrophil cytoplasmic antibody-associated vasculitis in Mexican Mestizos. Rheumatology (Oxford) 55(12):2271–2273CrossRef
36.
go back to reference Menegatti E, Davit A, Francica S, Berardi D, Rossi D, Baldovino S, Tovo PA, Sena LM, Roccatello D (2009) Genetic factors associated with rheumatoid arthritis and systemic vasculitis: evaluation of a panel of polymorphisms. Dis Markers 27(5):217–223CrossRefPubMedPubMedCentral Menegatti E, Davit A, Francica S, Berardi D, Rossi D, Baldovino S, Tovo PA, Sena LM, Roccatello D (2009) Genetic factors associated with rheumatoid arthritis and systemic vasculitis: evaluation of a panel of polymorphisms. Dis Markers 27(5):217–223CrossRefPubMedPubMedCentral
37.
go back to reference Weckmann AL, Granados J, Cardiel MH, Andrade F, Vargas-Alarcón G, Alcocer-Varela J, Alarcón-Segovia D (1999) Immunogenetics of mixed connective tissue disease in a Mexican Mestizo population. Clin Exp Rheumatol 17(1):91–94PubMed Weckmann AL, Granados J, Cardiel MH, Andrade F, Vargas-Alarcón G, Alcocer-Varela J, Alarcón-Segovia D (1999) Immunogenetics of mixed connective tissue disease in a Mexican Mestizo population. Clin Exp Rheumatol 17(1):91–94PubMed
38.
go back to reference Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DRW, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JSF, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KGC (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367(3):214–223CrossRefPubMedPubMedCentral Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DRW, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JSF, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KGC (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367(3):214–223CrossRefPubMedPubMedCentral
39.
go back to reference Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86(4):242–251CrossRef Ramos-Casals M, Brito-Zerón P, Muñoz S, Soria N, Galiana D, Bertolaccini L, Cuadrado MJ, Khamashta MA (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86(4):242–251CrossRef
40.
go back to reference Bienaimé F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP (2007) D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am J Kidney Dis 50(5):821–825CrossRefPubMed Bienaimé F, Clerbaux G, Plaisier E, Mougenot B, Ronco P, Rougier JP (2007) D-Penicillamine-induced ANCA-associated crescentic glomerulonephritis in Wilson disease. Am J Kidney Dis 50(5):821–825CrossRefPubMed
Metadata
Title
Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity
Authors
Eduardo Martín-Nares
Diego Zuñiga-Tamayo
Andrea Hinojosa-Azaola
Publication date
01-01-2019
Publisher
Springer London
Published in
Clinical Rheumatology / Issue 1/2019
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-018-4212-1

Other articles of this Issue 1/2019

Clinical Rheumatology 1/2019 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.